Neonatal abstinence syndrome: Difference between revisions
(Text replacement - " US " to " ultrasound ") |
|||
| Line 30: | Line 30: | ||
*Opiates when supportive measures fail | *Opiates when supportive measures fail | ||
*Morphine is 1st line for infants exposed to '''both''' opioids and benzos | *Morphine is 1st line for infants exposed to '''both''' opioids and benzos | ||
*Longer acting buprenorphine may significantly reduce hospital admission and treatment duration as compared to morphine<ref>Kraft WK et al. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome. May 4, 2017DOI: 10.1056/NEJMoa1614835.</ref> | |||
**Morphine q4 hours vs. buprenorphine q8 hours if NAS scale > 12 | |||
**[[Buprenorphine]] dosed initially at 5 mcg/kg q8 hrs to max dose of 20 mcg/kg q8 hrs | |||
**Neonatal morphine 0.4mg/ml PO sln | **Neonatal morphine 0.4mg/ml PO sln | ||
***Watch for side effect limiting dose (urinary retention) | ***Watch for side effect limiting dose (urinary retention) | ||
Revision as of 03:08, 28 May 2017
Background
- Incidence has quadrupled since 1999 from 1.5 per 1000 hospital births to 6.0 per 1000 in 2013[1]
- Condition caused by neonatal withdrawal from substance exposure in utero
- Withdrawal within first 24-48 hrs → fetal alcohol syndrome
- Withdrawal within 48-72 hrs → heroin
- Withdrawal at 7-14 days → methadone
- Polysubstance withdrawal must also be considered
Clinical Features
- Agitated - high-pitched cry, restlessness, tremors, hypertonia, convulsions
- Vasomotor - sweating, fever
- Respiratory - nasal congestion, persistent sneezing, RR > 60/min, nasal flaring
- Metabolic - poor feeding, vomiting, loose stools
Differential Diagnosis
- Neonatal sepsis
- Hyperthyroidism/hypothyroidism
- Hypocalcemia
- Hypoglycemia
- Vertically transmitted diseases (HepB, HepC, HIV, etc.)
- Other withdrawal (caffeine, cocaine, nicotine, amphetamines, SSRIs)
Evaluation
- Pharmacologic treatment when 3 consecutive ≥ 8 on NAS(Finnegan scale
- Enzyme immunoassay, urine toxicology, meconium analysis
- Consider cranial ultrasound for cocaine-exposed neonates with abnormal neurologic signs
Management
- Supportive - swaddling to decrease sensory stimulation, frequent small feedings of 24 cal/oz formula
- Opiates when supportive measures fail
- Morphine is 1st line for infants exposed to both opioids and benzos
- Longer acting buprenorphine may significantly reduce hospital admission and treatment duration as compared to morphine[2]
- Morphine q4 hours vs. buprenorphine q8 hours if NAS scale > 12
- Buprenorphine dosed initially at 5 mcg/kg q8 hrs to max dose of 20 mcg/kg q8 hrs
- Neonatal morphine 0.4mg/ml PO sln
- Watch for side effect limiting dose (urinary retention)
- Withdrawal symptoms need to be stabilized for 3-5 days before taper
- Mother's methadone < 50mg (or other opiate)
- Start morphine PO sln 0.1mg/kg q3hrs with feeds
- Increase by 0.1mg/kg hourly if NAS score ≥ 8, max 1mg/kg
- Mother's methadone > 50mg
- Start 0.2mg/kg q3hrs
- Increase by 0.2mg/kg hourly if NAS score ≥ 8, max 1mg/kg
- If NPO, use preservative free morphine at 50 mcg/ml
- Load 30 mcg/kg over 1hr, then infusion at 2 mcg/kg/hr
- Increase by 1 mcg/kg/hr hourly until NAS < 8, max 6 mcg/kg/hr
- Benzo withdrawal treatment
- Midazolam 0.1mg/kg IV q3hrs or 0.3mg/kg PO q3hrs
- OR phenobarbital 3mg/kg IV or PO q24hrs
- Phenobarbital for seizures OR side effect limiting morphine effects OR max morphine dose reached
- 16mg/kg load divided into two consecutive feedings for day 1
- 24 hrs later, use 2-8mg/kg/day maintenance dose
Disposition
- Admit
See Also
References
- Hudak ML, Tan RC. Neonatal Drug Withdrawal. Pediatrics. January 2012. 129(2):e540-560.
- Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care. 2005 Oct. 5(5):265-72.
- Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014 Aug. 134(2):e527-34.
- Pullen L. Neonatal Abstinence Syndrome: Stringent Weaning Protocol Best. Available at http://www.medscape.com/viewarticle/829115. Accessed: August 12, 2016.
